Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Improving antithrombotic management in patients with atrial fibrillation: current status and perspectives

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Anabolic-Androgenic Steroid Abuse Impairs Fibrin Clot Lysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hemostasis in Pediatric Cardiac Surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pregnancy and Antiphospholipid Syndrome

    Research output: Contribution to journalReviewResearchpeer-review

  1. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Marcel Levi
  • F D Richard Hobbs
  • Alan K Jacobson
  • Ron Pisters
  • Domenico Prisco
  • Artur Bernardo
  • Markus Haas
  • Jens Heidrich
  • Matt Rosenberg
  • Jørn Dalsgaard Nielsen
  • Walter A Wuillemin
View graph of relations

Despite overwhelming evidence of the benefits of risk-adjusted oral anticoagulation on stroke reduction in patients with atrial fibrillation (AF), there is still considerable undertreatment. A multidisciplinary expert group was formed to discuss issues surrounding anticoagulant treatment of patients with AF to try and achieve consensus on various aspects of the implementation of guidelines on oral anticoagulation therapy in AF. Panel members were cardiologists, hematologists, and laboratory and primary care physicians with specific expertise from Europe and the United States. One of the most important conclusions of the meeting was to enhance guideline adherence by better communication of the data showing that the benefits of stroke reduction outweigh the risk of bleeding associated with treatment with vitamin K antagonists. Management of oral anticoagulation therapy by dedicated centers, such as anticoagulation clinics, or by patient self-management may improve the quality of anticoagulation and facilitate the management of these patients and thereby further facilitate optimal antithrombotic management in patients with AF.

Original languageEnglish
JournalSeminars in Thrombosis and Hemostasis
Volume35
Issue number6
Pages (from-to)527-42
Number of pages16
ISSN0094-6176
DOIs
Publication statusPublished - Sep 2009

    Research areas

  • Anticoagulants/therapeutic use, Atrial Fibrillation/drug therapy, Guideline Adherence, Humans, Practice Guidelines as Topic, Risk Factors, Stroke/prevention & control

ID: 61881897